Jian He

First Affiliated Hospital of Zhengzhou University — China

Medicine · Health Sciences

17h-index1.1kcitations71works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(24), Advanced Radiotherapy Techniques(14), Lung Cancer Treatments and Mutations(10), Radiomics and Machine Learning in Medical Imaging(10), Inflammatory Biomarkers in Disease Prognosis(8)

Publications71 total

Updated results of anlotinib combined with penpulimab and nab-paclitaxel as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.
Journal of Clinical Oncology·2026
Treatment Options for TASC II C and D Aorto-iliac Occlusive Disease: A Systematic Review and Network Meta-analysis
Journal of Endovascular Therapy·2025
Research on the Urban Development Resilience and Sustainability Based on Data Analysis and Model Construction
Mathematical Modeling and Algorithm Application·2025Open Access
Non-Digestible Oligosaccharides and Constipation: A Systematic Review and Meta-Analysis of Randomized Trials on Stool Frequency, Stool Consistency, and Fermentation Biomarkers
Nutrients·2025Open Access
Optimisation of Water and Sand Flux Evolution and Monitoring in the Lower Reaches of the Yellow River Xiaolangdi Based on Multivariate Statistics and Time Series Analysis
Mathematical Modeling and Algorithm Application·2025Open Access
WITHDRAWN: 155P Establishment of a clinical translational model for personalized chemotherapy of lung cancer based on cell cycle dynamics
Annals of Oncology·2025
SSL-CL-RUS - A Semi-Supervised Framework for Renal Ultrasound Segmentation in CKD: Combining Pseudo-Label Guided Contrastive Learning with ST++
2025
Theranostic radionuclides labeled biodegradable microspheres for the treatment of hepatocellular carcinoma with radioembolization
Radiation Physics and Chemistry·2025· 4 cited
Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers
BMC Cancer·2025Open Access
Impact of ground-glass component on prognosis in early-stage lung cancer treated with stereotactic body radiotherapy via Helical Tomotherapy
Radiation Oncology·2024· 1 citedOpen Access
Successful treatment of large hemoptysis and pseudoaneurysm of the pulmonary artery associated to oesophagomediastinal fistula with amphotericin B cholesterol sulfate complex: A case report
Respirology Case Reports·2024· 1 citedOpen Access
Pharmacological Inhibition of Necroptosis Promotes Human Breast Cancer Cell Proliferation and Metastasis [Retraction]
OncoTargets and Therapy·2024Open Access
3407: efficacy and toxicity of moderately hypofractionated radiotherapy via helical tomotherapy versus conventional radiotherapy combined with concurrent chemotherapy for patients with unresectable stage III non-small cell Lung Cancer: a multicenter, randomized phase III trial Chinese clinical trial registration: ChiCTR1800017367
Radiotherapy and Oncology·2024
Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial
International Journal of Radiation Oncology*Biology*Physics·2024· 14 citedOpen Access
Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy
Frontiers in Oncology·2023· 7 citedOpen Access
NALCN is a potential biomarker and therapeutic target in human cancers
Frontiers in Genetics·2023· 7 citedOpen Access
Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
Radiation Oncology·2023· 9 citedOpen Access
Additional file 5 of Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
Figshare·2023Open Access
Additional file 7 of Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
Figshare·2023Open Access
Additional file 2 of Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof
Figshare·2023Open Access
page 1 of 4Next →

Frequent Co-authors

Zhao‐Chong Zeng(22), Shiming Shi(11), Luxi Ye(9), Yan Huang(7), Qianqian Zhao(6), Jia Fan(5), Gang Chen(5), Yong Hu(5), Shaonan Fan(5), Shisuo Du(4), Yixing Chen(4), Xiaohong Xu(4), Zuo‐Lin Xiang(3), Jingwen Xia(3), Xiangou Pan(3), Yong Hu(3), Tingting Li(3), Wenhan Huang(3), Xuan Li(2), Ping Yang(2)